186 related articles for article (PubMed ID: 23359272)
21. Sonodynamic Therapy Using Dacarbazine-Loaded AuSiO
Esmailzadeh A; Shanei A; Attaran N; Hejazi SH; Hemati S
Ultrasound Med Biol; 2022 Jun; 48(6):1131-1142. PubMed ID: 35307236
[TBL] [Abstract][Full Text] [Related]
22. Parthenolide enhances dacarbazine activity against melanoma cells.
Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
[TBL] [Abstract][Full Text] [Related]
23. Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
Engesæter B; Engebraaten O; Flørenes VA; Mælandsmo GM
PLoS One; 2012; 7(9):e45492. PubMed ID: 23029050
[TBL] [Abstract][Full Text] [Related]
24. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM
Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672
[TBL] [Abstract][Full Text] [Related]
25. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
26. Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
Najar HM; Dutz JP
J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132
[TBL] [Abstract][Full Text] [Related]
27. Dacarbazine inhibits proliferation of melanoma FEMX-1 cells by up-regulating expression of miRNA-200.
Chen YN
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1191-1197. PubMed ID: 28387914
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
Yang C; Cao H; Liu N; Xu K; Ding M; Mao LJ
Drug Des Devel Ther; 2016; 10():3755-3761. PubMed ID: 27895465
[TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.
de Oliveira SI; Andrade LN; Onuchic AC; Nonogaki S; Fernandes PD; Pinheiro MC; Rohde CB; Chammas R; Jancar S
BMC Cancer; 2010 May; 10():200. PubMed ID: 20465821
[TBL] [Abstract][Full Text] [Related]
30. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
[TBL] [Abstract][Full Text] [Related]
31. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.
Bill MA; Fuchs JR; Li C; Yui J; Bakan C; Benson DM; Schwartz EB; Abdelhamid D; Lin J; Hoyt DG; Fossey SL; Young GS; Carson WE; Li PK; Lesinski GB
Mol Cancer; 2010 Jun; 9():165. PubMed ID: 20576164
[TBL] [Abstract][Full Text] [Related]
32. Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32) - in vitro studies.
Szlasa W; Supplitt S; Drąg-Zalesińska M; Przystupski D; Kotowski K; Szewczyk A; Kasperkiewicz P; Saczko J; Kulbacka J
Biomed Pharmacother; 2020 Dec; 132():110883. PubMed ID: 33113417
[TBL] [Abstract][Full Text] [Related]
33. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells.
Biteghe FN; Davids LM
J Photochem Photobiol B; 2017 Jan; 166():18-27. PubMed ID: 27852006
[TBL] [Abstract][Full Text] [Related]
34. Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
Zhang C; Hao Y; Wu L; Dong X; Jiang N; Cong B; Liu J; Zhang W; Tang D; De Perrot M; Zhao X
Int J Oncol; 2018 Dec; 53(6):2531-2541. PubMed ID: 30272283
[TBL] [Abstract][Full Text] [Related]
35. Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.
Heere-Ress E; Boehm J; Thallinger C; Hoeller C; Wacheck V; Birner P; Wolff K; Pehamberger H; Jansen B
J Invest Dermatol; 2005 Aug; 125(2):201-6. PubMed ID: 16098027
[TBL] [Abstract][Full Text] [Related]
36. Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells.
Pisano M; Pagnan G; Dettori MA; Cossu S; Caffa I; Sassu I; Emionite L; Fabbri D; Cilli M; Pastorino F; Palmieri G; Delogu G; Ponzoni M; Rozzo C
Mol Cancer; 2010 Jun; 9():137. PubMed ID: 20525240
[TBL] [Abstract][Full Text] [Related]
37. Acid ceramidase expression modulates the sensitivity of A375 melanoma cells to dacarbazine.
Bedia C; Casas J; Andrieu-Abadie N; Fabriàs G; Levade T
J Biol Chem; 2011 Aug; 286(32):28200-9. PubMed ID: 21700700
[TBL] [Abstract][Full Text] [Related]
38. Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening.
Liu X; Sun K; Song A; Zhang X; Zhang X; He X
World J Surg Oncol; 2014 Dec; 12():389. PubMed ID: 25523120
[TBL] [Abstract][Full Text] [Related]
39. Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
Thangasamy T; Sittadjody S; Mitchell GC; Mendoza EE; Radhakrishnan VM; Limesand KH; Burd R
BMC Cancer; 2010 Jun; 10():282. PubMed ID: 20540768
[TBL] [Abstract][Full Text] [Related]
40. Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance.
Sanches LJ; Marinello PC; da Silva Brito WA; Lopes NMD; Luiz RC; Cecchini R; Cecchini AL
Cell Biol Int; 2022 Jan; 46(1):73-82. PubMed ID: 34506671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
